Porton Pharma Solutions Ltd (300363):企業の財務・戦略的SWOT分析

◆英語タイトル:Porton Pharma Solutions Ltd (300363) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH447815FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Porton Pharma Solutions Ltd (Porton) is involved in the supply of intermediate drugs and active pharmaceutical ingredients. The company provides custom and contract chemical development, and contract manufacturing services. It is also involved in providing research and development and production services. The company’s product portfolio includes reactive reagents, chiral chromatography products, unnatural amino acids and heterocylics, among others. It also offers regulatory support for the commercialization of active pharmaceutical ingredients and intermediates of APIs. Porton offers gene cell therapy services and analytical quality control services. The company also operates its business across the US region. Porton is headquartered in Chongqing, China.

Porton Pharma Solutions Ltd Key Recent Developments

Mar 15,2021: Proton Pharmaceutical and METiS announce a strategic cooperation
Sep 18,2020: Porton received certificate of appreciation from Ethiopian Ministry of Health
May 21,2020: Porton launches an integrated cGMP Solutions Suite at its Chongqing Process Technology Center, China
May 13,2020: Porton Shanghai Formulation R&D Center launched Construction
Apr 21,2020: Porton successfully receives third US FDA Inspection

This comprehensive SWOT profile of Porton Pharma Solutions Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Porton Pharma Solutions Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Porton Pharma Solutions Ltd – Key Information
Porton Pharma Solutions Ltd – Overview
Porton Pharma Solutions Ltd – Key Employees
Porton Pharma Solutions Ltd – Key Employee Biographies
Porton Pharma Solutions Ltd – Key Operational Heads
Porton Pharma Solutions Ltd – Major Products and Services
Porton Pharma Solutions Ltd – History
Porton Pharma Solutions Ltd – Company Statement
Porton Pharma Solutions Ltd – Locations And Subsidiaries
Porton Pharma Solutions Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Porton Pharma Solutions Ltd – Business Description
Porton Pharma Solutions Ltd – Corporate Strategy
Porton Pharma Solutions Ltd – SWOT Analysis
SWOT Analysis – Overview
Porton Pharma Solutions Ltd – Strengths
Porton Pharma Solutions Ltd – Weaknesses
Porton Pharma Solutions Ltd – Opportunities
Porton Pharma Solutions Ltd – Threats
Porton Pharma Solutions Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Porton Pharma Solutions Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Porton Pharma Solutions Ltd, Key Information
Porton Pharma Solutions Ltd, Key Ratios
Porton Pharma Solutions Ltd, Share Data
Porton Pharma Solutions Ltd, Major Products and Services
Porton Pharma Solutions Ltd, History
Porton Pharma Solutions Ltd, Key Employees
Porton Pharma Solutions Ltd, Key Employee Biographies
Porton Pharma Solutions Ltd, Key Operational Heads
Porton Pharma Solutions Ltd, Other Locations
Porton Pharma Solutions Ltd, Subsidiaries
Porton Pharma Solutions Ltd, Key Competitors
Porton Pharma Solutions Ltd, SWOT Analysis
Porton Pharma Solutions Ltd, Ratios based on current share price
Porton Pharma Solutions Ltd, Annual Ratios
Porton Pharma Solutions Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Porton Pharma Solutions Ltd (300363):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fluor Corporation:戦略・SWOT・企業財務分析
    Fluor Corporation - Strategy, SWOT and Corporate Finance Report Summary Fluor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Siliconware Precision Industries Co Ltd:企業の戦略的SWOT分析
    Siliconware Precision Industries Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • VertiFlex Inc:医療機器:M&Aディール及び事業提携情報
    Summary VertiFlex Inc (Vertiflex) is a medical device company that offers invasive treatments for lumbar stenosis. The company offers products such as interspinous spacer and direct decompression systems. Its interspinous spacer system is a motion-preserving, indirect decompression spinal implant sy …
  • Euro India Fresh Foods, Ltd. (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods, Ltd. (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Halo Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization holds specialization in the development of m …
  • BEENOS Inc.:企業のM&A・事業提携・投資動向
    BEENOS Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BEENOS Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Immune Design Corp (IMDZ):企業の財務・戦略的SWOT分析
    Summary Immune Design Corp (Immune Design) is a clinical-stage immunotherapy company that discovers and develops in vivo immunotherapy treatments to target cancer and other chronic diseases. The company harnesses ZVex and GLAAS discovery platforms, to develop its product portfolio. Immune Design’s p …
  • Maruho Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Maruho Co Ltd (Maruho) is a pharmaceutical company that carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers produ …
  • Toyo Tire & Rubber Co Ltd (5105):企業の財務・戦略的SWOT分析
    Toyo Tire & Rubber Co Ltd (5105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Powerco Ltd:企業の戦略的SWOT分析
    Powerco Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CJ ENM Co., Ltd. (035760):企業の財務・戦略的SWOT分析
    CJ ENM Co., Ltd. (035760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Catalyst Pharmaceuticals Inc (CPRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as infantile spasms, complex partial seizures, Lambert-Eaton myasthenic syndrome (LE …
  • Blackline Safety Corp. (BLN):企業の財務・戦略的SWOT分析
    Blackline Safety Corp. (BLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • DHL Supply Chain (formerly Exel Inc.):戦略・SWOT・企業財務分析
    DHL Supply Chain (formerly Exel Inc.) - Strategy, SWOT and Corporate Finance Report Summary DHL Supply Chain (formerly Exel Inc.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Liberty Mutual Group Inc:企業のM&A・事業提携・投資動向
    Liberty Mutual Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Liberty Mutual Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Meidensha Corporation:企業の戦略・SWOT・財務情報
    Meidensha Corporation - Strategy, SWOT and Corporate Finance Report Summary Meidensha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • IHI Corporation (7013)-エネルギー分野:企業M&A・提携分析
    Summary IHI Corporation (IHI) is a heavy machinery engineering group. It provides technology oriented products and services to customers in the public, private and industrial sectors across the world. The group designs and manufactures a diverse range of products including ships and offshore facilit …
  • Landmark Graphics Corp:企業の戦略的SWOT分析
    Landmark Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Amplyx Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Amplyx Pharmaceuticals Inc (Amplyx) is a developer of antifungal medicines. The company develops antifungal agents for the treatment of life-threatening invasive fungal infections due to candidia, aspergillus and rare molds. It also develops small molecule therapy APX001, which is in clinica …
  • Core-Mark Holding Company, Inc.:企業の戦略・SWOT・財務情報
    Core-Mark Holding Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Core-Mark Holding Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆